Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IMVT |
---|---|---|
09:32 ET | 13311 | 26.27 |
09:34 ET | 2288 | 26.305 |
09:36 ET | 2428 | 26.3975 |
09:38 ET | 354 | 26.44 |
09:39 ET | 550 | 26.42 |
09:41 ET | 1790 | 26.33 |
09:43 ET | 2887 | 26.19 |
09:45 ET | 3476 | 25.85 |
09:48 ET | 17694 | 26.06 |
09:50 ET | 6263 | 26.025 |
09:52 ET | 6794 | 25.985 |
09:54 ET | 2381 | 26.155 |
09:56 ET | 900 | 26.09 |
09:57 ET | 1872 | 26.145 |
09:59 ET | 983 | 26.09 |
10:01 ET | 6701 | 26.015 |
10:03 ET | 13773 | 25.99 |
10:06 ET | 20283 | 25.81 |
10:08 ET | 5115 | 25.8 |
10:10 ET | 11142 | 25.695 |
10:12 ET | 4525 | 25.8 |
10:14 ET | 2950 | 25.64 |
10:15 ET | 4979 | 25.65 |
10:17 ET | 2123 | 25.67 |
10:19 ET | 6498 | 25.59 |
10:21 ET | 6955 | 25.79 |
10:24 ET | 3376 | 25.85 |
10:26 ET | 1257 | 25.89 |
10:28 ET | 1950 | 25.805 |
10:30 ET | 300 | 25.84 |
10:32 ET | 8335 | 25.8 |
10:33 ET | 69329 | 25.8101 |
10:35 ET | 6354 | 25.74 |
10:37 ET | 4887 | 25.64 |
10:39 ET | 3164 | 25.63 |
10:42 ET | 8962 | 25.63 |
10:44 ET | 1500 | 25.66 |
10:46 ET | 4943 | 25.62 |
10:48 ET | 4743 | 25.68 |
10:50 ET | 9713 | 25.73 |
10:51 ET | 1932 | 25.78 |
10:53 ET | 2429 | 25.695 |
10:55 ET | 3246 | 25.69 |
10:57 ET | 3892 | 25.64 |
11:00 ET | 1666 | 25.75 |
11:02 ET | 5757 | 25.775 |
11:04 ET | 2810 | 25.61 |
11:06 ET | 6174 | 25.615 |
11:08 ET | 660 | 25.61 |
11:09 ET | 23872 | 25.79 |
11:11 ET | 51200 | 25.77 |
11:13 ET | 7501 | 25.8 |
11:15 ET | 2890 | 25.915 |
11:18 ET | 2546 | 25.885 |
11:20 ET | 10695 | 26.045 |
11:22 ET | 7797 | 25.99 |
11:24 ET | 5244 | 26.04 |
11:26 ET | 153961 | 26.035 |
11:27 ET | 767 | 26 |
11:29 ET | 8428 | 26.01 |
11:31 ET | 4875 | 26 |
11:33 ET | 300 | 26 |
11:36 ET | 1400 | 25.97 |
11:38 ET | 6279 | 25.86 |
11:40 ET | 3200 | 25.76 |
11:42 ET | 1954 | 25.78 |
11:44 ET | 2090 | 25.6601 |
11:45 ET | 6672 | 25.685 |
11:47 ET | 1548 | 25.7 |
11:49 ET | 1000 | 25.68 |
11:51 ET | 1753 | 25.69 |
11:54 ET | 3853 | 25.78 |
11:56 ET | 2477 | 25.88 |
11:58 ET | 6905 | 25.96 |
12:00 ET | 4595 | 25.89 |
12:02 ET | 953 | 25.89 |
12:03 ET | 7759 | 25.92 |
12:05 ET | 1105 | 25.9 |
12:07 ET | 5895 | 25.9157 |
12:09 ET | 2766 | 25.885 |
12:12 ET | 682 | 25.88 |
12:14 ET | 1018 | 25.88 |
12:16 ET | 1030 | 25.89 |
12:18 ET | 5169 | 25.97 |
12:20 ET | 4567 | 25.84 |
12:21 ET | 3485 | 25.73 |
12:23 ET | 2736 | 25.7 |
12:25 ET | 1801 | 25.67 |
12:27 ET | 1244 | 25.66 |
12:30 ET | 4044 | 25.63 |
12:32 ET | 7621 | 25.63 |
12:34 ET | 2323 | 25.7 |
12:36 ET | 1800 | 25.7 |
12:38 ET | 3709 | 25.6 |
12:39 ET | 7103 | 25.52 |
12:41 ET | 1300 | 25.5099 |
12:43 ET | 1950 | 25.46 |
12:45 ET | 5458 | 25.535 |
12:48 ET | 2627 | 25.42 |
12:50 ET | 2202 | 25.46 |
12:52 ET | 1024 | 25.46 |
12:54 ET | 3369 | 25.47 |
12:56 ET | 2000 | 25.45 |
12:57 ET | 4350 | 25.4 |
12:59 ET | 147570 | 25.53 |
01:01 ET | 4908 | 25.6 |
01:03 ET | 2431 | 25.57 |
01:06 ET | 3100 | 25.57 |
01:08 ET | 3272 | 25.5 |
01:10 ET | 2600 | 25.44 |
01:12 ET | 4736 | 25.41 |
01:14 ET | 9294 | 25.378 |
01:15 ET | 3413 | 25.38 |
01:17 ET | 2200 | 25.325 |
01:19 ET | 3420 | 25.33 |
01:21 ET | 6565 | 25.3 |
01:24 ET | 2072 | 25.31 |
01:26 ET | 7461 | 25.23 |
01:28 ET | 9658 | 25.24 |
01:30 ET | 458 | 25.26 |
01:32 ET | 1497 | 25.25 |
01:33 ET | 4309 | 25.22 |
01:35 ET | 3420 | 25.195 |
01:37 ET | 14042 | 25.17 |
01:39 ET | 3337 | 25.18 |
01:42 ET | 1600 | 25.19 |
01:44 ET | 12477 | 25.2 |
01:46 ET | 800 | 25.185 |
01:48 ET | 12680 | 25.1601 |
01:50 ET | 23860 | 25.16 |
01:51 ET | 8284 | 25.2 |
01:53 ET | 8245 | 25.09 |
01:55 ET | 3337 | 25.1 |
01:57 ET | 1560 | 25.135 |
02:00 ET | 5224 | 25.105 |
02:02 ET | 38342 | 25.17 |
02:04 ET | 1857 | 25.18 |
02:06 ET | 1500 | 25.165 |
02:08 ET | 5506 | 25.145 |
02:09 ET | 6180 | 25.16 |
02:11 ET | 4972 | 25.18 |
02:13 ET | 5014 | 25.16 |
02:15 ET | 4694 | 25.22 |
02:18 ET | 1497 | 25.21 |
02:20 ET | 3071 | 25.17 |
02:22 ET | 2484 | 25.1499 |
02:24 ET | 4482 | 25.135 |
02:26 ET | 2711 | 25.2125 |
02:27 ET | 6722 | 25.17 |
02:29 ET | 3020 | 25.135 |
02:31 ET | 3471 | 25.12 |
02:33 ET | 2005 | 25.105 |
02:36 ET | 4703 | 25.16 |
02:38 ET | 1865 | 25.12 |
02:40 ET | 7059 | 25.2 |
02:42 ET | 2257 | 25.18 |
02:44 ET | 54421 | 25.22 |
02:45 ET | 10140 | 25.195 |
02:47 ET | 5150 | 25.18 |
02:49 ET | 7189 | 25.04 |
02:51 ET | 17470 | 25.1 |
02:54 ET | 4024 | 25.1 |
02:56 ET | 9450 | 25.14 |
02:58 ET | 102787 | 25.23 |
03:00 ET | 25996 | 25.3 |
03:02 ET | 3667 | 25.345 |
03:03 ET | 4254 | 25.275 |
03:05 ET | 3097 | 25.295 |
03:07 ET | 11388 | 25.16 |
03:09 ET | 6341 | 25.23 |
03:12 ET | 4760 | 25.22 |
03:14 ET | 6013 | 25.175 |
03:16 ET | 7172 | 25.12 |
03:18 ET | 20633 | 25.0325 |
03:20 ET | 9608 | 25.022 |
03:21 ET | 14667 | 25.02 |
03:23 ET | 19881 | 24.9 |
03:25 ET | 5702 | 24.89 |
03:27 ET | 6021 | 24.93 |
03:30 ET | 106037 | 24.92 |
03:32 ET | 6530 | 24.968 |
03:34 ET | 9978 | 24.965 |
03:36 ET | 15606 | 25.05 |
03:38 ET | 12083 | 24.9901 |
03:39 ET | 20524 | 25.01 |
03:41 ET | 11069 | 25.02 |
03:43 ET | 11843 | 25.045 |
03:45 ET | 18050 | 25 |
03:48 ET | 18569 | 25.12 |
03:50 ET | 11996 | 25.07 |
03:52 ET | 24272 | 25.135 |
03:54 ET | 52805 | 25.39 |
03:56 ET | 26607 | 25.4 |
03:57 ET | 32586 | 25.32 |
03:59 ET | 42203 | 25.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunovant Inc | 3.7B | -13.5x | --- |
Crinetics Pharmaceuticals Inc | 3.5B | -11.8x | --- |
Merus NV | 3.6B | -19.5x | --- |
Nuvalent Inc | 4.2B | -27.2x | --- |
Dyne Therapeutics Inc | 3.1B | -8.0x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
Immunovant, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for patients with autoimmune diseases. Its product pipeline includes batoclimab (IMVT-1401), and IMVT-1402, both of which are novel, fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor (FcRn). Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD). IMVT-1402 is a fully human monoclonal antibody that inhibits FcRn. IMVT-1402 has also been observed in nonclinical studies to reduce IgG antibody levels. IMVT-1402 is delivered as a 2 mL simple subcutaneous injection.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 146.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-1.89 |
Book Value | $4.24 |
P/E Ratio | -13.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.